Colin D. Weekes, M.D., PhD
Colin D. Weekes, M.D., PhD
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer | pancreatic adenocarcinoma | Active, not recruiting | Phase 2 | 2026-09-11 | NCT05077800 |